国泰中证沪港深创新药产业ETF发起联接A(014117)资产配置 |
|
报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
2024/3/31 |
0 |
305,836 |
58,446,900 |
55,971,000 |
0% |
2023/12/31 |
33,055 |
304,259 |
66,296,500 |
65,444,500 |
0% |
2023/9/30 |
0 |
302,409 |
48,927,700 |
47,859,900 |
0% |
2023/6/30 |
0 |
- |
47,125,500 |
44,757,700 |
0% |
2023/3/31 |
0 |
- |
37,944,400 |
37,477,800 |
0% |
2022/12/31 |
0 |
405,136 |
26,082,700 |
24,979,600 |
0% |
2022/9/30 |
0 |
403,700 |
26,452,900 |
25,918,000 |
0% |
2022/6/30 |
0 |
- |
24,875,700 |
23,253,500 |
0% |
2022/3/31 |
0 |
- |
20,461,500 |
19,818,500 |
0% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。